Literature DB >> 1913476

Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.

D L Ornstein1, L R Zacharski, V A Memoli, W Kisiel, B J Kudryk, J Hunt, S M Rousseau, D C Stump.   

Abstract

Mechanisms of coagulation activation in situ were studied by means of immunohistochemical techniques applied to surgically resected primary adenocarcinomas and squamous cell carcinomas of the lung. Findings in these two histologic types were similar. Double-labeling techniques using macrophage-specific antibody together with antibody to either tissue factor, factor VII, factor X, or factor V revealed coincident staining for each of these coagulation factors on tumor-associated macrophages. Staining of tumor cells for these factors was rare and inconsistent. Both macrophages and fibroblasts in the tumor connective tissue stained for the a subunit of factor XIII. Fibrinogen was abundant throughout the tumor connective tissue, but staining for fibrin and D-dimer cross-linked sites of fibrin was restricted to areas adjacent to macrophages, indicating that thrombin was generated in association with tumor macrophages but not with tumor cells. By contrast, tumor cells stained diffusely for urokinase-type plasminogen activator and focally for thrombomodulin. These findings contrast with those reported previously for small cell carcinoma of the lung and suggest that coagulation activation in adenocarcinoma and squamous cell carcinoma of the lung may occur indirectly through activation of certain host cells such as macrophages. By contrast, tumor cell plasminogen activator may mediate certain aspects of the malignant phenotype in these tumor types.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913476     DOI: 10.1002/1097-0142(19910901)68:5<1061::aid-cncr2820680525>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.

Authors:  I Bolon; M Devouassoux; C Robert; D Moro; C Brambilla; E Brambilla
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Trousseau's syndrome.

Authors:  N Callander; S I Rapaport
Journal:  West J Med       Date:  1993-04

4.  Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.

Authors:  E Heinmöller; R J Weinel; H H Heidtmann; U Salge; R Seitz; I Schmitz; K M Müller; H Zirngibl
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 6.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

7.  Expression and localization of thrombomodulin in preneoplastic bronchial lesions and in lung cancer.

Authors:  E Tolnay; T Wiethege; K M Müller
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

8.  The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.

Authors:  J L Francis; N Carty; M Amirkhosravi; M Loizidou; A Cooper; I Taylor
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

9.  Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis.

Authors:  M Sawada; S Miyake; S Ohdama; O Matsubara; S Masuda; K Yakumaru; Y Yoshizawa
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 10.  Venous thromboembolism and lung cancer: a review.

Authors:  Carolina Vitale; Maria D'Amato; Paolo Calabrò; Anna Agnese Stanziola; Mauro Mormile; Antonio Molino
Journal:  Multidiscip Respir Med       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.